1PFE trade ideas
paper trading pfe 09 feb 2021Disclaimer:
This information is for educational purposes and is not an investment recommendation or representative of professional expertise. This analysis used herein is for illustration purposes only. This personal opinion should not be considered specific investment advice. I am not responsible for any trades, and individuals are solely responsible for any live trades placed in their own personal accounts.
continue in line
$35,08 this is critical area for pfizer inc price can long to level price $36,10 or short to level price $34,15
good luck and happy profit
My recommended 25 stocks portfolio for 8-12 February After beating the market 4 weeks in row with compound profits of 54.14%, in 4 weeks this is my recommended portfolio of 25 stocks for the trading week 8-12 February 2021:
1- AAPL@ 136.76
2- CRSP @ 168.81
3- CSCW @ 0.9759
4- EBON @ 5.83
5- EYES @ 2.45
6- FB @ 268.10
7- FSR @ 14.99
8- GNUS @ 1.88
9- GOEV @ 17.63
10- MRIN @ 2.78
11- PAYS @ 5.16
12- PFE @ 34.92
13- PLTR @ 34.05
14- PRQR @ 5
15- PSTI @ 6.78
16- SIOX @ 3.01
17- SOLO @ 8.69
18- STAF @ 1.11
19- THMO @ 3.27
20- TLGT @ 1.02
21- TWTR @ 56.78
22- VLDR @ 23.25
23- VRM @ 46.71
24- WISA @ 3.70
25- WORX @ 2.27
Do your diligent work an always manage your risk.
Wish you a profitable week!
Moshkelgosha
Pfizer - a safebetRising triangle has been broken on the upside. Upside is the base of the the of triangle, $10.
It may reach ATH, ~$46.
PFIZER at the base of a potential bullish channel.I have bee following closely this stock for a couple of months now and I did notice this potential opportunity after the last drop.
$PFE Oversold and bullish signalLooks like the stock is just about to touch a very stong resistance and potentially heading back up
Buy the Drug DipThis one surprised me with a poor earnings report, but my outlook remains the same. All indicators point to a bounce.
paper trading pfe 05 feb 2021Disclaimer:
This information is for educational purposes and is not an investment recommendation or representative of professional expertise. This analysis used herein is for illustration purposes only. This personal opinion should not be considered specific investment advice. I am not responsible for any trades, and individuals are solely responsible for any live trades placed in their own personal accounts.
$35,08 this is critical area for pfizer inc price can long to level price $36,10 or short to level price $34,15
good luck and happy profit
PFE - EW analysis - ABC cycle down PFE - The 3rd of C wave down in progress within ABC zigzag cycle down. Stay bearish on bounce for more downside.
Give thumbs up if you really like the trade idea/analysis.
paper trading pfe 03 feb 2021Disclaimer:
This information is for educational purposes and is not an investment recommendation or representative of professional expertise. This analysis used herein is for illustration purposes only. This personal opinion should not be considered specific investment advice. I am not responsible for any trades, and individuals are solely responsible for any live trades placed in their own personal accounts.
for today price moving in line channel trading area and price go to $34,16
good luck and happy profit,
LONG PFEPrice retest support line
Potential entry $34.50 and below
Pfizer’s fourth-quarter results were mixed as it missed estimates for earnings while beating the same for sales. Pfizer’s financial outlook for 2021 was quite upbeat.
paper trading pfe 03 feb 2021Disclaimer:
This information is for educational purposes and is not an investment recommendation or representative of professional expertise. This analysis used herein is for illustration purposes only. This personal opinion should not be considered specific investment advice. I am not responsible for any trades, and individuals are solely responsible for any live trades placed in their own personal accounts.
secara daily harga akan bergerak turun ke level 34,09
good luck and happy profit
Pfizer Inc. (PFE)Pfizer reported fourth-quarter earnings of 42 cents per share, below the 50 cents expected by consensus while revenue was 11.7 billion, slightly above expectations of 11.5 billion. The pharmaceutical group, however, surprised the market by indicating that it is witnessing that sales of the anti-covid vaccine produced together with the German BioNTech will generate sales of 15 billion dollars in the 2021 while consensus expectations were steady at 12.7.
